Likely Diagnosis: Intermittent Restless Legs Syndrome (RLS)
This patient's presentation is most consistent with intermittent Restless Legs Syndrome (RLS), a neurological sensorimotor disorder that can present with episodic patterns and predominantly affects women. 1
Diagnostic Reasoning
The clinical picture strongly suggests RLS based on the following alignment with diagnostic criteria 2:
Features Supporting RLS Diagnosis:
- Restless legs with muscle aches: The uncomfortable sensations and urge to move legs are hallmark features
- Insomnia and nighttime waking: RLS causes sleep disturbance in approximately 90% of patients, with difficulty falling and staying asleep 1
- Evening/nighttime predominance: Symptoms occurring at night align with criterion #4 (circadian pattern)
- Episodic pattern (every 1-2 months): Meets criteria for intermittent RLS - defined as symptoms occurring <2 times per week on average over the past year with at least 5 lifetime events 2
- Female sex: RLS is roughly 50% more prevalent in females 1
- Age 30: RLS can affect all age ranges 3
Key Distinguishing Features:
The absence of joint pain, joint swelling, and fever effectively rules out inflammatory arthritides and systemic rheumatologic conditions. The lack of menstrual correlation excludes premenstrual syndrome or menstrual-related disorders 2.
Critical Diagnostic Steps
You must systematically exclude RLS mimics - this is formalized in the 2012 diagnostic criteria as essential criterion #5 2:
Mimics to Rule Out:
- Leg cramps (sudden, painful muscle contractions)
- Positional discomfort (relieved by position change, not movement)
- Venous stasis/leg edema (visible swelling)
- Peripheral neuropathy (constant symptoms, not circadian)
- Myalgia from other causes
- Habitual foot tapping
Important caveat: Without proper differential diagnosis, 16% of subjects without RLS can be misclassified 2. The key distinguishing feature is that true RLS symptoms are partially or totally relieved by movement (walking, stretching) and show clear circadian worsening in evening/night 2.
Supportive Diagnostic Features to Assess
Evaluate these additional factors that strengthen RLS diagnosis 2:
- Family history: Very common in idiopathic RLS with autosomal-dominant pattern 4
- Iron status: Check serum ferritin - levels <75 μg/L (some suggest <20% transferrin saturation) are associated with RLS 1, 5
- Response to dopaminergic therapy: Positive response is supportive
- Periodic limb movements: Can be documented by polysomnography if diagnosis uncertain 2
Secondary Causes to Investigate
Given the 2-year duration and episodic pattern, screen for secondary RLS 6, 7:
- Iron deficiency: Most important reversible cause - check CBC, ferritin, transferrin saturation 5
- Chronic kidney disease: Check renal function
- Medications: Antidepressants, antipsychotics, antihistamines can trigger/worsen RLS 7
- Pregnancy history: Can unmask RLS 4
- Peripheral neuropathy: Though less likely given symptom pattern 7
Alternative Consideration: Fibromyalgia
While less likely given the episodic pattern, fibromyalgia should remain on the differential 8. However, fibromyalgia typically presents with:
- More constant widespread pain (not episodic weekly episodes)
- Multiple tender points
- Associated cognitive symptoms ("fibro fog")
- Less dramatic circadian variation
The clear episodic pattern with week-long episodes every 1-2 months, combined with prominent restless legs and nighttime waking, makes RLS more probable than fibromyalgia.
Recommended Diagnostic Approach
- Apply formal RLS diagnostic criteria systematically 2
- Check iron studies (ferritin, transferrin saturation, CBC) - iron deficiency is highly treatable 1, 5
- Review medication list for RLS-exacerbating drugs 7
- Check basic metabolic panel (renal function) 6
- Assess family history of similar symptoms 4
Management Implications
If RLS is confirmed and iron deficiency identified, iron supplementation is first-line treatment 1, 5. For intermittent RLS without iron deficiency, treatment may be reserved for symptomatic episodes or preventive therapy before anticipated symptom periods, using dopamine agonists or alpha-2-delta ligands 1.
The episodic nature (intermittent RLS) may allow for intermittent treatment strategies rather than continuous daily therapy, which can help avoid long-term complications like augmentation with dopaminergic agents 1.